Atlas FDA

VENTANNA PATHWAY HER-2 (CLONE CB11)

FDA premarket approval P990081/S005 · decided 2007-04-11

Approval details

PMA number
P990081
Supplement
S005
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VENTANNA PATHWAY HER-2 (CLONE CB11)
Generic name
SYSTEM, TEST, HER-2/NEU, IHC
Applicant
Ventana Medical Systems, Inc.
Date received
2007-03-02
Decision date
2007-04-11
Days to decision
40 days
Decision code
APPR
Product code
MVC
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
APPROVAL FOR CHANGE IN THE LABELING TO INCLUDE THE PATHWAY HER-2 4 IN 1 CONTROL SLIDES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20